On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.” ...

Copyright 2025 The Associated Press. All Rights Reserved. Containers of Zyn, a smokeless nicotine pouch, are displayed for sale among other nicotine and tobacco ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches can help adult smokers cut back or switch completely. The Food ...

After "an extensive scientific review," the FDA said, the products were found to pose lower risks of cancer and other serious ...

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

The company did not admit wrongdoing in the settlement. Zyn, an alternative to traditional chewing tobacco products, is a nicotine pouch that does not contain tobacco. Nicotine in adolescence can ...

The FDA determined that due to substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products, the authorized nicotine pouches pose a lower risk for cancer ...